Alps Advisors Inc Keros Therapeutics, Inc. Transaction History

Alps Advisors Inc

  • $14.8 Billion
  • Q3 2024

A detailed history of Alps Advisors Inc transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 27,905 shares of KROS stock, worth $1.56 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
27,905
Previous 28,144 0.85%
Holding current value
$1.56 Million
Previous $1.29 Million 25.97%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$41.68 - $58.07 $9,961 - $13,878
-239 Reduced 0.85%
27,905 $1.62 Million
Q2 2024

Aug 13, 2024
BUY
$44.58 - $66.89 $123,308 - $185,017
2,766 Added 10.9%
28,144 $1.29 Million
Q1 2024

May 14, 2024
BUY
$41.26 - $70.48 $237,905 - $406,387
5,766 Added 29.4%
25,378 $1.68 Million
Q4 2023

Feb 14, 2024
SELL
$27.12 - $41.05 $61,860 - $93,635
-2,281 Reduced 10.42%
19,612 $779,000
Q3 2023

Nov 14, 2023
BUY
$31.57 - $43.02 $4,703 - $6,409
149 Added 0.69%
21,893 $697,000
Q2 2023

Aug 14, 2023
BUY
$37.26 - $51.01 $109,507 - $149,918
2,939 Added 15.63%
21,744 $873,000
Q1 2023

May 10, 2023
BUY
$41.44 - $59.32 $4,889 - $6,999
118 Added 0.63%
18,805 $802,000
Q4 2022

Feb 14, 2023
BUY
$39.45 - $51.77 $184,034 - $241,507
4,665 Added 33.27%
18,687 $897,000
Q3 2022

Nov 14, 2022
SELL
$27.8 - $40.12 $6,672 - $9,628
-240 Reduced 1.68%
14,022 $528,000
Q2 2022

Aug 11, 2022
SELL
$26.03 - $67.04 $270,946 - $697,819
-10,409 Reduced 42.19%
14,262 $394,000
Q1 2022

May 16, 2022
SELL
$42.12 - $59.36 $101,088 - $142,464
-2,400 Reduced 8.87%
24,671 $1.34 Million
Q4 2021

Feb 09, 2022
SELL
$36.95 - $62.89 $56,459 - $96,095
-1,528 Reduced 5.34%
27,071 $1.58 Million
Q3 2021

Nov 15, 2021
SELL
$29.27 - $43.71 $61,115 - $91,266
-2,088 Reduced 6.8%
28,599 $1.13 Million
Q2 2021

Aug 11, 2021
BUY
$42.4 - $70.11 $1.3 Million - $2.15 Million
30,687 New
30,687 $1.3 Million

Others Institutions Holding KROS

# of Institutions
174
Shares Held
30.3M
Call Options Held
76.8K
Put Options Held
9K
View Full List

About Keros Therapeutics, Inc.

KROS Quotes by TradingView
  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $1.44B
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email